Tucked inside a 3,000-page national defense bill signed into law last month is a set of new regulations that could upend the way local biotech companies do business. The Biosecure Act, as it is known, ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Evercrisp Biosciences, Inc., a portfolio company of Apple Tree Partners, entered bankruptcy within a month of a filing by ...

Jarez Holz says 2026 will be a strong year for biotech stocks. The Mizuho analyst explained why in a recent CNBC interview.

One of the biotech industry’s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug ...

In The Star's annual year in review, the county's biggest business stories included housing proposals and the aftermath of a ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

Boston CEOs point to a rise in funding rounds and M&A deals in late 2025 as evidence that biotech companies are learning to ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. The ...

Abivax SA soared about 1,300% after successful trial results for a bowel disease drug, Argenx SE was added to the elite Euro Stoxx 50 Index and smaller names including Valneva SE and Inventiva also ...

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of ...